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The susceptibility of adopted children to infection correlates more with the susceptibility of their biologic parents than with that of their adoptive parents.1 This suggests that genetic factors can increase the risk of 
infection. These factors are often genetic polymorphisms, but in a few cases mono-
genic defects underlie vulnerability to repeated infections. Genetic studies of sus-
ceptibility to infection have typically focused on defects of antibody production, or 
a lack of T cells, phagocytes, natural killer cells, or complement, each of which can 
cause a classic immunodeficiency syndrome. Recently, genetic defects have been 
identified that impair recognition of pathogens by the innate immune system, in-
creasing susceptibility to specific classes of microorganisms. For example, defects 
in the interferon-γ pathway have been implicated in recalcitrant infections by intra-
cellular pathogens such as mycobacteria and salmonella.2,3 In this review, we focus 
on types of immunodeficiencies in which defects in pattern-recognition receptors 
and their downstream intracellular pathways predominate.
Pattern-Recognition Receptors and Innate Immunity
During an encounter with a pathogen, cells of the innate immune system recognize 
conserved structures of the microbe called pathogen-associated molecular pat-
terns.4 Complement factor 1q, C-reactive protein, and fibronectin also recognize 
microbial structures but are not usually considered pathogen-recognition recep-
tors.5 Cells of the innate immune system recognize pathogen-associated molecular 
patterns by means of germline-encoded pattern-recognition receptors, which allow 
for semispecific recognition of pathogens. An example of such a receptor is the 
macrophage mannose receptor, discovered in 1990.6 In 1992, Charles Janeway, Jr., 
took the field of innate immunity in a new direction with his concept of selective 
recognition of conserved microbial structures by pattern-recognition receptors.7
There are four classes of pattern-recognition receptors: toll-like receptors 
(TLRs), C-type lectin receptors (CLRs), nucleotide-binding oligomerization domain 
(NOD) leucine-rich-repeat containing receptors (NLRs), and retinoic acid–inducible 
gene I protein (RIG-I) helicase receptors.4 Table 1 summarizes the properties of 
these receptors and the corresponding pathogen-associated molecular patterns. 
These patterns are constituents of microbial cell-wall components, microbial nu-
cleic acids, or metabolic products. We use the term pattern-recognition receptor to 
mean a cellular receptor that causes activation of innate immunity; we do not in-
clude molecules that microorganisms use for attachment to and invasion of host 
cells.
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Families of Pattern-Recognition Receptors
Toll-like Receptors
The role of TLRs in antimicrobial defense was 
described in 1996 by Lemaitre and colleagues,8 
who observed that fruit flies lacking the insect 
homologue of a toll receptor rapidly die from as-
pergillosis. Since then, 13 mammalian TLRs have 
been discovered. All the extracellular domains of 
these receptors contain leucine-rich repeats that 
recognize microbial structures; the amino acid 
sequence of the cytoplasmic domain of the toll–
interleukin-1 receptor is highly homologous with 
the sequences in the interleukin-1 receptor and 
the interleukin-18 receptor.9 Ligand recognition 
by TLRs and intracellular signal transduction by 
adaptor molecules activate kinase cascades and 
translocate transcription factors to the nucleus, 
where they induce gene expression and produc-
tion of cytokines (Fig. 1).4,10,11 In addition to 
their role in innate immunity, TLRs and other 
pattern-recognition receptors activate antigen-
presenting cells and bridge innate and adaptive 
immunity by coordinating responses of T cells 
and B cells.12,13
C-Type Lectin Receptors
The large family of CLRs includes dectin-1, mac-
rophage mannose receptor, dendritic-cell–specific 
intercellular adhesion molecule 3–grabbing non-
integrin, dectin-2, and the circulating mannose-
binding lectin. These receptors have carbohydrate-
recognition domains14 and recognize microbial 
polysaccharides. They appear to be essential for 
recognition of fungi and bacteria in the body.15
Cytoplasmic Pattern-Recognition Receptors
In addition to the mainly membrane-bound TLRs 
and CLRs, there are cytoplasmic pattern-recogni-
tion receptors — RIG-I helicase receptors and 
NLRs — that pathogens activate when they in-
vade a cell. RIG-I helicase receptors are receptors 
mainly for the nucleic acids of viruses. NLRs rec-
ognize the peptidoglycans of bacterial cell walls 
and can activate inflammasomes, which are mul-
tiprotein complexes that convert inactive pro–
interleukin-1β and pro–interleukin-18 into active 
cytokines (Fig. 1).16-18 The NOD-containing re-
ceptors 1 and 2 (NOD1 and NOD2), members of 
the NLR family, recognize the muramyl peptide 
moieties of the peptidoglycans of gram-negative 
and gram-positive bacteria, respectively.19,20 In-
teractions between the different pattern-recogni-
tion–receptor related pathways are essential for 
optimal antipathogen responses.21-26 Synergy be-
tween TLRs and NOD2, for example, is crucial 
for activation of the defense against mycobacte-
ria and staphylococci,27 and cross-talk between 
TLRs and CLRs is needed for antifungal respons-
es of the innate immune system.21
Defects in Pattern-Recognition 
Receptors
Polymorphisms in genes encoding pattern-recog-
nition receptors can affect susceptibility to infec-
tion. In addition, genetic defects in these recep-
tors or the allied downstream pathways can 
cause immunodeficiency. We know of defects in 
three of the four classes of pattern-recognition 
receptors: TLRs, CLRs and NLRs (Table 2). To 
our knowledge, no deficiency of the RIG-I heli-
case receptors has been found.
Defects of TLRs
MyD88 and IRAK-4
Myeloid differentiation factor 88 (MyD88) is an 
adaptor molecule that transduces signals from 
TLR receptors (with the exception of TLR3) and 
from the receptors for interleukin-1 and interleu-
kin-18.28,29 The signaling involves a cascade of 
protein kinases, including the serine–threonine 
kinase IRAK-4.10 Studies in the past decade have 
identified germline mutations in IRAK-430-37 and 
MYD8838 in patients with increased susceptibility 
to pyogenic bacteria and pseudomonas species. 
These defects in the TLR–interleukin-1 receptor 
pathway were found in young patients with re-
current, severe pneumococcal infections. The 
lymphocytes of one of the first reported patients 
had a poor response, in vitro, to stimulation with 
endotoxin and interleukin-1.39 The invasive infec-
tions associated with these mutations are usually 
meningitis and septicemia caused by Streptococcus 
pneumoniae and Staphylococcus aureus and less fre-
quently by Pseudomonas aeruginosa and salmonella 
species. S. aureus is the main cause of localized 
infection, but P. aeruginosa and S. pneumoniae can 
also cause this complication.40
Invasive infections begin to appear in infancy, 
with a cumulative mortality of 30 to 40%.36 Chil-
dren with an MyD88 or IRAK-4 deficiency, by 
contrast, do not have major infections when they 
reach adulthood.40 This difference suggests that 
the development of protective T-cell and B-cell 
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Table 1. Overview of Pattern-Recognition Receptors (PRRs) and Their Respective Pathogen-Associated Molecular Pattern (PAMP) Ligands, 
According to PRR Class.*
Recognized PAMP Microorganism in Which PAMP Is Found Signaling Molecule
TLRs
TLR2-1
Triacyl lipopeptides Bacteria MyD88–TIRAP
TLR2-2 MyD88–TIRAP
Peptidoglycan Bacteria
Lipoarabinomannan Mycobacteria
Phospholipomannan Candida
Glycosylphosphatidylinositol Trypanosoma
TLR2-6 MyD88–TIRAP
Diacyl lipopeptides Mycoplasma
Lipoteichoic acid Streptococcus
Zymosan Saccharomyces
TLR3 TRIF
ssRNA virus West Nile virus
dsRNA virus Reovirus
TLR4 MyD88–TIRAP, TRIF–TRAM
Lipopolysaccharide Gram-negative bacteria
Fungal mannans Candida
Envelope proteins Respiratory syncytial virus
TLR5
Flagellin Flagellated bacteria MyD88
TLR7 and TLR8
ssRNA viruses Influenza virus, vesicular stomatitis virus MyD88
TLR9 MyD88
dsDNA viruses Herpes simplex virus
CpG motifs Bacterial and fungal DNA
CLRs
Mannose receptor
Fungal mannans Candida Unknown
Dectin-1
Beta-1,3-glucans Fungi SYK–CARD9, RAF1
Dectin-2–FcRγ
Mannans Candida hyphae SYK–CARD9
MINCLE–FcRγ SYK
Mannans Candida
Mycobacterial cord factor Mycobacteria
Mannose-binding lectin Soluble receptor
Repetitive oligosaccharides Bacteria and fungi
NLRs
NOD1
Muramyl tripeptide peptidoglycans Gram-negative bacteria RIP2
NOD2
Muramyl dipeptide peptidoglycans Gram-positive bacteria RIP2
NLRP1
Anthrax toxin Bacillus anthracis ASC–caspase-1
NLRP3
Peptidoglycans Bacteria
Bacterial toxins Listeria, staphylococcus
NLRC4
Flagellin Shigella, salmonella, legionella ASC–NAIP5, caspase-1
AIM2
dsDNA Francisella tularensis ASC–caspase-1
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mediated immunity after infancy compensates for 
the defective TLR–interleukin-1 receptor pathway.36
TLR3–UNC93B Pathway
Two classes of intracellular pattern-recognition 
receptors, the RIG-I helicase receptors and TLRs, 
recognize viruses. The intracellular receptors 
TLR3, TLR7, TLR8, and TLR9 bind to microbial 
nucleic acids.41 To our knowledge, no defects in 
the RIG-I helicase-receptor family are known. Pa-
tients with mutations in TLR342 or in UNC93B1, 
a protein in the TLR3 pathway,43 are prone to 
recurrent encephalitis caused by herpesvirus. The 
disease occurs mainly in early childhood (from 
3 months to 6 years of age) during an initial in-
fection with herpes simplex virus type 1.40,44
TLR3 deficiency seems to be associated only 
with encephalitis caused by a herpes simplex 
virus; children with the deficiency have normal 
resistance to other pathogens. Recurrences have 
been documented in two patients, suggesting a 
role for TLR3 in herpesvirus latency.40 A de-
creased capacity to release type I interferons was 
found in one patient’s fibroblasts; blocking TLR3-
dependent induction of interferons in vitro en-
hanced viral replication and caused cell death, 
effects that were reversed by recombinant inter-
feron-β.42 The role of inadequate levels of type I 
interferons in susceptibility to herpesvirus en-
cephalitis was also shown in a child who was 
deficient in the signal transducer and activator 
of transcription 1 protein,45,46 a signaling mol-
ecule in the type I interferon pathway.
TLR5
TLR5 is a receptor for flagellin, a protein that 
forms the pathogen-associated molecular pattern 
of the flagellum in flagellated bacteria.47 Hawn 
and colleagues48 described a polymorphism of 
TLR5 (consisting of a stop codon at position 392) 
that impairs recognition of flagellin and increas-
es susceptibility to legionella pneumonia. The 
phenotype associated with this polymorphism is 
mild and affects the control of only certain flag-
ellated pathogens. The frequency of this stop-
codon allele in European populations is as high 
as 10%; carriers of the allele are susceptible to 
infection with Legionella pneumophila48 and to re-
current cystitis,49 but not to infection with the 
flagellated bacterium Salmonella enterica serotype 
Typhi, the agent of typhoid fever.50 Protective ef-
fects of this TLR5 polymorphism against systemic 
lupus erythematosus and Crohn’s disease have 
been reported.51,52 The high and variable popula-
tion frequencies of the polymorphism suggest 
that it has a redundant role in host defense.53
Defects of CLRs
CLRs form a large family that specifically recog-
nizes carbohydrate structures of microorgan-
isms and endogenous ligands.15 They have a role 
in the recognition of fungal pathogens and my-
cobacteria.
Dectin-1–CARD9 Pathway
Dectin-1 is the major pattern-recognition recep-
tor for beta-1,3-glucan in the fungal cell wall54,55 
Table 1. (Continued.)
Recognized PAMP Microorganism in Which PAMP Is Found Signaling Molecule
RIG-I helicase receptors
RIG-I IPS1
Short dsRNA Paramyxoviruses, orthomyxoviruses, rhabdoviruses, 
flaviviruses
5′ Triphosphate ssRNA Paramyxoviruses, orthomyxoviruses, rhabdoviruses, 
flaviviruses
MDA5
Long dsRNA Picornaviruses, reoviruses, flaviviruses IPS1
* AIM2 denotes absent in melanoma 2 protein, ASC apoptosis-associated speck-like protein containing a CARD, CARD9 caspase recruitment 
domain–containing protein 9, CLR C-type lectin receptor, CpG cytosine phosphate guanidine, ds double-stranded, FcRγ Fc receptor IgE 
high-affinity I gamma polypeptide, IPS1 interferon-β promoter stimulator protein 1, MDA5 melanoma differentiation-associated protein 5, 
MINCLE macrophage-inducible C-type lectin, MyD88 myeloid differentiation factor 88, NAIP5 NLR family apoptosis inhibitory protein 5, 
NLR nucleotide-binding oligomerization domain (NOD) leucine-rich-repeat–containing receptors, NLRC4 NLR family CARD-domain–con-
taining protein 4 (also known as IPAF), NLRP NOD leucine-rich-repeat and pyrin domain–containing protein, RAF1 raf proto-oncogene ser-
ine–threonine protein kinase, RIG-I retinoic acid–inducible gene I protein, RIP2 receptor-interacting protein 2, ss single-stranded, SYK 
spleen tyrosine kinase, TIRAP toll-like–receptor adaptor protein, TLR toll-like receptor, TLR2-1 TLR2–TLR1 heterodimers, TLR2-2 TLR2–TLR2 
heterodimers, TLR2-6 TLR2–TLR6 heterodimers, TRAM TRIF-related adaptor molecule, and TRIF toll-like receptor–adaptor molecule.
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and in unknown components of Mycobacterium 
tuberculosis.56 Genetic analyses of members of a 
family with recurrent vulvovaginal candidiasis and 
onychomycosis identified an early stop codon in 
CLEC7A (the gene encoding dectin-1), causing a 
loss of 10 amino acids from the extracellular car-
bohydrate-recognition domain of the protein.57 
In consequence, the cell cannot display dectin-1 
on its membrane, thereby negating the ability of 
monocytes to bind beta-glucans. This defect im-
pairs the production of interleukin-6, tumor ne-
crosis factor, and especially interleukin-17. In 
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Figure 1. The Four Major Classes of Pattern-Recognition Receptors and Their Most Important Ligands.
The four classes are toll-like receptors (TLRs), C-type lectin receptors (CLRs), nucleotide-binding oligomerization domain (NOD) leucine-
rich-repeat (LRR)–containing receptors (NLRs), and retinoic acid–inducible gene I protein (RIG-I) helicase receptors. NLRs, the central 
components of the inflammasomes, are complex protein platforms that lead to the activation of caspase 1 and interleukin-1β process-
ing. The most extensively studied inflammasomes are as follows: the NOD leucine-rich-repeat and pyrin domain–containing protein 3 
(NLRP3) inflammasome, activated by bacterial and fungal pathogen-associated molecular patterns; the NLR family caspase recruitment 
domain–containing protein (CARD) 4 (NLRC4) inflammasome, activated during intracellular bacterial infections by flagellin; and the ab-
sent in melanoma 2 (AIM2) inflammasome, activated by double-stranded (ds) DNA. ASC denotes apoptosis-associated speck-like pro-
tein containing a CARD, HIN hematopoietic interferon-inducible nuclear protein, IRF3 interferon regulatory factor 3, LPS lipopolysaccha-
ride, MAL myelin and lymphocyte protein, MDA5 melanoma differentiation-associated protein 5, MR mineralocorticoid receptor, MyD88 
myeloid differentiation factor 88, NF-κB nuclear factor-κB, NLRC4 NLR family CARD-domain–containing protein 4 (also known as IPAF), 
ss single-stranded, SYK spleen tyrosine kinase, TRAM TRIF-related adaptor molecule, and TRIF toll-like–receptor adaptor molecule.
The New England Journal of Medicine 
Downloaded from nejm.org at RADBOUD UNIVERSITEIT NIJMEGEN on February 11, 2013. For personal use only. No other uses without permission. 
 Copyright © 2011 Massachusetts Medical Society. All rights reserved. 
mechanisms of disease
n engl j med 364;1 nejm.org january 6, 2011 65
contrast, neutrophils from affected persons can 
ingest and kill Candida albicans normally, indicat-
ing redundancy of dectin-1 in the phagocytosis 
and killing of yeast. Defective cytokine release 
most likely explains the phenotype. Defective 
dectin-1 signaling in epithelial cells and intraepi-
thelial gamma–delta T cells may also contribute 
to the clinical picture, especially since these cells 
express dectin-1 and produce cytokines and anti-
microbial peptides on activation.58,59
We should be cautious in concluding that ge-
netic variants of the gene encoding dectin-1 have 
a role in disease. About 6 to 8% of Europeans are 
heterozygous for a disabling variant of the gene, 
which implies that approximately 1 in 400 Euro-
peans has a deficiency of the protein; they do not, 
however, have an apparent immunodeficiency. In 
some African populations, such as the San peo-
ple of southern Africa, the allele frequency reach-
es almost 40%.57 The phenotype of patients with 
dectin-1 deficiency is relatively mild and less se-
vere than that of patients with classic chronic 
mucocutaneous candidiasis.60,61 Heterozygous car-
riers of the dectin-1 polymorphism are more likely 
to be colonized with C. albicans when undergoing 
stem-cell transplantation, and need antifungal 
therapy more often, than noncarriers.62 For all 
these reasons, dectin-1 deficiency resembles a ge-
netic polymorphism, which in some people or 
under some circumstances is associated with sus-
ceptibility to fungi but not with severe immuno-
deficiency.
CARD9
Several members of a family with increased sus-
ceptibility to infection with fungi,63 mucocutane-
ous fungal infections in particular, have been 
shown to have mutations in caspase recruitment 
domain–containing protein 9 (CARD9), the adap-
tor molecule that mediates signaling induced by 
dectin-1. These clinical findings support the role 
of the beta-glucan recognition pathway in anti-
fungal defense. A severe defect of interleukin-17 
production has been reported in patients with 
CARD9 mutations.63 The more severe phenotype 
of CARD9 deficiency is most likely due to mecha-
nisms that are independent of dectin-1.64-66
Mannose-Binding Lectin
Some components of the complement system 
that have the capacity to interact with microbial 
polysaccharides can function as recognition re- T
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ceptors. The complement molecule that most 
closely resembles a pattern-recognition receptor 
is mannose-binding lectin, which binds carbohy-
drate structures of microorganisms and activates 
the complement system.67 Deficiency in man-
nose-binding lectin was initially reported in an 
infant with recurrent bacterial infections and has 
been associated with bacterial infections (espe-
cially with Neisseria meningitidis), in addition to 
fungal and viral infections.68-70 Subsequent stud-
ies showed, however, that polymorphisms in the 
mannose-binding lectin gene result in low levels 
of mannose-binding lectin in approximately 40% 
of whites, with very low levels in about 8%. Most 
people in the general population with low or high 
levels of mannose-binding lectin do not have ob-
vious clinical consequences. Thus, deficiency of 
mannose-binding lectin should be considered a 
risk factor for infection rather than an outright 
immunodeficiency.71
Other leukocyte molecules that recognize mi-
crobial polysaccharides are the β2-integrins, such 
as complement receptor 3 (CD11b–CD18), which 
is known to function as a neutrophil beta-glucan 
receptor72 as well as playing a part in leukocyte 
adhesion. The immunologic defects in patients 
with β2-integrin deficiency (leukocyte adhesion 
deficiency I) are mainly due to defective leuko-
cyte adhesion.73 Neither complement factors nor 
β2-integrins are considered classic pattern-rec-
ognition receptors.5,74
NLRs
Members of the large family of intracellular NLRs 
have two major functions: NOD1 and NOD2 rec-
ognize bacterial peptidoglycans,19,20 and NOD leu-
cine-rich-repeat and pyrin domain–containing 
proteins (NLRPs) participate in the formation of 
inflammasomes and the processing of inter leu-
kin-1β–interleukin-18 (Fig. 1).16,17
NOD2
Genetic defects in the pattern-recognition recep-
tor NOD2 constitute a major mechanism in 
Crohn’s disease. Mutations that affect the leu-
cine-rich-repeat domain of NOD2 occur in famil-
ial cases of Crohn’s disease.75,76 In another gran-
ulomatous disease, Blau’s syndrome — a rare 
autosomal dominant disorder characterized by the 
early onset of granulomatous inflammation and 
camptodactyly — there is a mutation in the nu-
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Figure 2. Clinical Features of Defects in Pattern-Recognition Receptors.
The major pathophysiological disturbance in syndromes characterized by 
defective pattern-recognition receptors is dysregulated cytokine-production 
capacity. This could come about by means of defective cytokine production 
(e.g., in cases of myeloid differentiation factor 88 [MyD88] or serine–threo-
nine kinase IRAK-4 deficiency, dectin-1 or caspase recruitment domain–
containing protein 9 [CARD9] deficiency, or toll-like receptor 3 [TLR3] or 
UNC93B [a protein in the TLR3 pathway] deficiency) or increased cytokine 
production (e.g., high interleukin-1β production in the case of the nucleotide-
binding oligomerization domain [NOD] leucine-rich-repeat–containing re-
ceptor [NLR] family pyrin-domain–containing protein 3 [NLRP3] deficiency). 
One exception is deficiency of mannose-binding lectin (MBL), which leads 
to defective complement activation. IRF3 denotes interferon regulatory fac-
tor 3, NF-κB nuclear factor-κB, NOD2 NOD-containing receptor 2, RIP2 re-
ceptor-interacting protein 2, and SYK spleen tyrosine kinase.
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cleotide-binding domain of NOD2.77 Missense 
mutations in the NACHT domain of NOD2 in 
several families with Blau’s syndrome caused a 
gain-of-function phenotype with increased basal 
activation of the transcription factor nuclear factor-
κB and uncontrolled inflammation.77
Does the NOD2 defect cause the inflammation 
in patients with Crohn’s disease?78,79 Most of the 
data indicate a loss-of-function mutation in NOD2, 
resulting in decreased production of defensins in 
the gut mucosa80 and an unregulated cytokine 
response.81,82 These abnormalities could impair 
the elimination of invading microorganisms in 
the mucosa and thereby cause reactive granulo-
matous inflammation. Studies of autophagy genes 
(ATG16L1 and IRGM), which encode proteins that 
regulate the breakdown by the cell of its own 
constituents, add weight to the hypothesis that 
genetic defects affecting innate immunity lead to 
Crohn’s disease.83,84 Neutrophil dysfunction and 
unregulated cytokine responses are also found 
in patients with Crohn’s disease,85,86 leading some 
researchers to suggest that the disease is a pri-
mary immunodeficiency syndrome of gut muco-
sal immunity.87,88
NLRP3
The inflammasome is a protein platform that 
participates in activating caspase-1 and the pro-
inflammatory cytokines interleukin-1β and inter-
leukin-18. Members of the NLR family are com-
ponents of inflammasomes. The most extensively 
studied member of the NLR family is NLRP3. 
The NLRP3 gene encodes cryopyrin, which, when 
activated, assembles with other proteins into an 
inflammasome. Mutations in NLRP3 occur in the 
cryopyrin-associated periodic syndromes, such 
as the familial cold autoinflammatory syndrome, 
the Muckle–Wells syndrome, and neonatal-onset 
multisystem inflammatory disorder (NOMID, also 
known as the chronic infantile neurologic, cuta-
neous, and articular syndrome).89 Features of the 
familial cold autoinflammatory syndrome are 
cold-induced fever, urticaria, and constitutional 
symptoms; characteristics of the Muckle–Wells 
syndrome are fever, hives, sensorineural hearing 
loss, and arthritis unrelated to cold exposure; 
and NOMID is characterized by fever, urticaria, 
epiphyseal overgrowth of the long bones, and 
chronic aseptic meningitis.90 In these syndromes, 
the high level of interleukin-1β, due to increased 
production, causes most of the symptoms.91 How-
ever, a secondary role of interleukin-18 and inter-
leukin-33 cannot be ruled out because the in-
f lammasome also processes these cytokines. 
Immunodeficiency is not a feature of this group 
of diseases, which are autoinflammatory syn-
dromes. Deficiency of NLRP12, a protein that in-
hibits inflammation mediated by activated mono-
cytes, has recently been found in a form of 
autoinflammatory syndrome.92
Conclusions
The clinical features of defects in pattern-recog-
nition receptors are usually due to disturbed cy-
tokine homeostasis (Fig. 2) — either decreased 
cytokine production and increased susceptibility 
to infections (in the case of TLR3 or MyD88 defi-
ciency) or overwhelming release of cytokines (in 
the case of NLRP3 defects). The clinical presen-
tation ranges from severe (in cases of MyD88 and 
IRAK-4 deficiencies) to mild (in cases of man-
nose-binding lectin and TLR5 deficiencies). The 
clinical severity is greatest in infancy but decreas-
es thereafter, perhaps because adaptive immune 
responses that develop after infancy compensate 
for the ineffective innate immunity. By contrast, 
the level of severity of classic primary immunode-
ficiencies usually persists throughout life.
In 2007, Casanova and Abel predicted that the 
field of primary immunodeficiency would shift 
from research on rare familial defects in the adap-
tive immune response to studies of sporadic and 
selective disorders of innate immunity that are 
more common than the classic immunodeficien-
cies.93 The defects in pattern-recognition recep-
tors are an instructive example of this shift. The 
uncovering of these defects has given clinical rel-
evance to immunologic pathways, which until 
now have been studied exclusively in the labora-
tory or in experimental models of infection.
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